Encapsulation of specific molecules, such as drugs and genetic agents like CRISPR/Cas9, siRNA, and mRNA, into nanocarriers with tumor targeting strategy has led to address PFP resistance and represents promising strategy for effective induction of PANoptosis in specific cancer models. This evidence concerns the gene PRF1 and cancer.